Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Andrade Robert received 1,703 Fennec Pharmaceuticals Inc. shares as an award (Form 4)
Traded Jul 31, 2026 · Filed Aug 3, 2026
On Jul 31, 2026, Andrade Robert (CHIEF FINANCIAL OFFICER) received 1,703 Fennec Pharmaceuticals Inc. shares as an award, leaving 292,675 shares. Filed Aug 3, 2026 (Form 4).
- Awarded
- 1,703 shares
- Holding after
- 292,675 shares
- Trading plan
- No
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common shares | Award | 1,703 | 292,675 | Direct |
Source
Related
- Fennec Pharmaceuticals Inc.
- Andrade Robert
- Fennec Pharmaceuticals Inc. shareholders
- Form 4 · Andrade Robert · Nov 2, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Andrade Robert · Oct 1, 2026
- Form 4 · Andrade Robert · Aug 31, 2026
- Form 4 · Andrade Robert · Aug 28, 2026
- Form 4 · Brughera Marco Maria · Nov 16, 2026
- Schedule 13G/A · Lawrence Kam · Nov 16, 2026
- Schedule 13G/A · Solas Capital Management, LLC · Nov 16, 2026
- Form 4 · Cioffi Christiana Marie · Nov 2, 2026
- Form 4 · Evans Terry L · Nov 2, 2026